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Differences in perceived health status
between kidney transplant recipients
and dialyzed patients are based mainly
on the selection process
Kidney transplantation oﬀers longer survival and
less morbidity than dialysis. Moreover, the cost of
transplantation is lower (1). It is also reported
that quality of life is improved after kidney
transplantation (2, 3). While research into graft
and patient survival after transplantation is quite
impressive, studies focusing on quality of life,
functional status or perceived health status are less
common. Comparisons of health status between
patients after transplantation and those remaining
on dialysis are even less frequent and most were
published more than 10 yr ago. In general, two
diﬀerent populations are usually evaluated. When
considering deceased-donor kidney recipients, one
should be aware that patients being transplanted
come from a group of dialyzed patients who have
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Abstract: Kidney transplantation oﬀers longer survival, less morbidity
and lower costs than dialysis. It is also believed to improve quality of life.
The aim of this study was to compare prospectively the perceived health
status (PHS) of dialyzed patients on a waiting list with kidney transplant
recipients after transplantation, matched for age, gender and comorbidity.
The sample consisted of 93 dialyzed patients on a waiting list for deceased-
donor kidney transplantation and 87 incident transplant recipients. A
total of 62 dialyzed patients were matched for age, gender and comorbidity
with 62 transplant recipients. PHS was measured using the SF-36 ques-
tionnaire. Data from baseline and after 12 months were compared between
the groups. Patients on dialysis had worse physical (49 ± 21) and mental
(59 ± 18) PHS than transplant recipients (56 ± 21 and 64 ± 18,
p £ 0.05), but when matched pairs were compared, no diﬀerences in PHS
were found. After 12 months, PHS did not change signiﬁcantly in either
group. The PHS of patients after kidney transplantation is better than that
of those on dialysis. However, this fact is signiﬁcantly inﬂuenced by the
selection procedure, as only some dialyzed patients are put onto the waiting
list while others were actually transplanted. The diﬀerences disappear
with matching.
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been put on a waiting list. A patients ﬁrst step
towards getting on such a list is an evaluation, and
only if no contraindications are found, is s/he
placed on the waiting list. The second step takes
place when a suitable organ is available: the
patients actual condition is checked again before
transplant surgery. Transplantation is performed
only if there are no contraindications. Transplant
surgeons commonly choose the very best candi-
dates for transplantation carefully. In some pub-
lished studies, transplant recipients had only half
as much coronary and peripheral vascular disease
than patients on dialysis (4), and only 2.5% of
incident patients with end-stage renal disease
undergo transplantation as their initial modality
of treatment (5), which is in contrast to published
guidelines (6). Any comparison of the health status
of transplant recipients to patients on dialysis is
therefore biased by these two selection processes,
resulting in a comparison of young and relatively
healthy patients to older and more ailing ones (7).
The majority of research papers that explore
diﬀerences in quality of life between kidney trans-
plant recipients and dialyzed patients date from
more than 10 yr ago (from 1984 till 1996) and are
cross-sectional in design. Over the past 10–15 yr
dialysis technology and immunosuppressive treat-
ment have changed considerably. The indication
criteria for starting dialysis and for considering
transplantation have also changed. These shifts
have deﬁnitely altered the characteristics of our
patient sample when compared to samples from
previous periods. Another problem is the number
of transplant patients recruited in these studies,
ranging between 30 and 144 (8–14). Studies with
larger samples are rare, the exceptions being the
study by Muthny and Koch, who included 761
transplanted, 290 hemodialyzed and 68 peritoneal
dialysis patients (15); the study by Gudex with 367
transplanted, 144 hemodialyzed and 93 peritoneal
dialysis patients (16); the study by Wight et al. with
228 transplanted, 183 hemodialyzed and 109 peri-
toneal dialysis patients (3); and the study by
Reimer et al. with 149 transplanted and the same
number of both hemodialyzed patients and healthy
controls (17). All of the cited studies found better
quality of life in transplant recipients when com-
pared to dialyzed patients, but some of their
authors noted the heterogeneity within their sam-
ples. The diﬀerences in age between (younger)
transplanted and (older) dialyzed patients are the
most common ﬁndings (3, 8, 11, 15), but diﬀerent
lengths of time for treatment (3, 8, 15) and unequal
gender proportions (15) are reported as well. In
contrast to earlier ﬁndings, Morris and Jones did
not ﬁnd any striking diﬀerences in quality of life
between 69 transplanted and 24 home hemodialysis
patients. The authors found reduced quality of life
in 24 hospital hemodialysis patients compared with
transplant recipients, but also when compared with
home hemodialysis patients (18). Another study
showing no signiﬁcant diﬀerences in quality of life
was published by Johnson et al. Twenty kidney
transplant recipients were compared to 10 hemodi-
alyzed patients on a waiting list for kidney trans-
plantation, 19 hemodialyzed patients not on a
waiting list and 10 failed transplants. Only the latter
category showed diminished quality of life (19).
Very few studies with repeated evaluations of
quality of life before and after transplantation have
been published on this topic. Three studies contain
a low number of transplanted patients – 16 in the
study by Park et al. (12), 23 in the study by Kutner
et al. (20) and 27 in the study by Russell et al. (21).
Three larger studies have been published: Jofre
et al. tracked 88 kidney transplant recipients,
ﬁnding improvement in the Karnovsky Scale and
Sickness Impact Proﬁle scores after transplantation
compared to pre-transplant scores, but with diﬀer-
ences among genders (22); Laupacis et al. observed
a 20% improvement in health-related quality of life
(measured by the Sickness Impact Proﬁle and Time
Trade-Oﬀ Technique) in 168 transplant recipients,
76 of whom were followed-up two yr after trans-
plantation (2); and Manninen et al. followed-up
226 transplant recipients and found improved
work capacity among those with a functioning
graft (23). All of these papers, except for Kutner
et al., studied only transplant recipients without
any control group.
Our previous research focused on medical and
non-medical determinants of perceived health sta-
tus after transplantation. We found that perceived
health status, as a very complex construct, is
inﬂuenced by age, gender, education, employment
status, social support, side-eﬀects of treatment and
comorbidity, and not only by the success of
transplantation. The largest proportion of vari-
ability in perceived health status is attributed to
age and comorbidity (24). Because dialysis and
transplant patients diﬀer in these variables, their
perceived health status diﬀers, too (19). Therefore,
the central hypothesis was formulated that per-
ceived health status in patients with chronic kidney
disease is much more dependant on age, gender,
and comorbidity than on mode of therapy. In
focusing on these facts, the present study was
designed as a comparison of perceived health
status between dialyzed patients on a waiting list
for deceased-donor kidney transplantation and
incident kidney transplant recipients three months
after kidney transplantation, matched for age,
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gender and comorbidity, with prospective follow-
up after 12 months. This is a rather unique study
as only a few papers with a similar approach have
been published: Franke et al. studied 80 dialyzed
patients before and after transplantation focusing
on the role of social support and psychological
distress rather than on exploring diﬀerences
between dialyzed and transplanted patients (25);
Reimer et al. compared quality of life in 149
transplant recipients, 149 dialyzed patients and
149 healthy controls matched for age and gender,
but without matching them for comorbidity, ﬁnd-
ing the quality of life of transplant recipients to be
comparable with that of healthy controls (17).
Materials and methods
Sample and procedures
Two patient cohorts were examined – patients on
dialysis and those after transplantation. Two waves
of data collection were performed: one at baseline
(three months after transplantation in transplant
group), the second after 12 months. Dialysis
patients on a waiting list for deceased-donor kidney
transplantation were identiﬁed and matched for age
(in decades), gender and comorbidity category with
incident kidney transplant recipients from the same
region. Comorbidity was evaluated using informa-
tion about comorbid diseases from medical records
based on Wrights comorbidity index criteria (26).
Patients were then stratiﬁed as low-risk category (no
comorbidity), intermediate-risk (one comorbid con-
dition) or high-risk (more than one comorbid
condition).
The local Ethical Committee approved the
study. Only patients who signed informed consent
prior to the study were included.
Dialysis patients
Altogether 169 dialyzed patients from four diﬀer-
ent dialysis centers in the Slovak Republic were
invited to participate, but 18 patients refused or
provided incomplete data (a response rate of
89.3%). Out of these 151 respondents, 93 patients
were on waiting lists for deceased-donor kidney
transplantation. Non-respondents did not diﬀer
from participants either in age or gender. All
patients from the four dialysis centers which agreed
to participate were included except for 15 with
severe dementia and two with mental retardation
(dementia or mental retardation were listed in their
medical records). Only patients currently on a
waiting list for transplantation were included for
statistical analysis. All respondents fulﬁlling the
inclusion criteria were invited to participate in a
follow-up examination 12 months after the base-
line interview, but eight of them (8.6%) did not
respond or provided incomplete data.
Transplanted patients
A group of 127 incident kidney transplant recip-
ients three months after transplant surgery from
the same region of the Slovak Republic were
invited to participate, but 40 patients refused or
provided incomplete data, so 87 patients remained
(a response rate of 68.5%). Non-respondents did
not diﬀer from participants either in age or gender.
All newly transplanted patients with a functional
graft who agreed to participate were included
except for one with mental retardation (mental
retardation was listed in the medical record). All
respondents were invited to participate in a follow-
up examination 12 months after their transplanta-
tion, but 33 of them (37.9%) did not respond or
provided incomplete data.
Matching procedure
Respondents included for analysis were matched
for age, gender and comorbidity index. For age-
matching, 10 yr diﬀerence was tolerated. In addi-
tion, matched patients had to be of the same
gender and have the same comorbidity index. At
baseline, 62 matched pairs were identiﬁed. For the
follow-up examination, 33 patients on a waiting
list and 41 transplant patients remained for
analysis.
Measures
All participants were interviewed by trained per-
sonnel. The interview focused on basic demo-
graphic information (age, gender), education
(elementary, secondary or university), employment
status (employed full-time or part-time, and not
employed – disabled, retired or unemployed),
house-keeping activities (measured in hours per
week spent shopping, cooking, cleaning, or caring
for family members) and family status (single,
married, divorced or widowed).
Perceived health status was measured using the
Short Form Health Survey (SF-36). The SF-36 is a
36-item questionnaire for the assessment of per-
ceived health status (27). It consists of eight sub-
scales which can be combined as a physical
summary component and a mental summary
component. All sub-scales as well as the summary
components are presented as scores between 0 and
100, with higher scores indicating better health
Rosenberger et al.
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status. The validity and reliability of the SF-36
have been validated in patients with renal disease,
including those after kidney transplantation (3, 25,
28, 29). Skalska et al. validated the questionnaire
in the Czech population (which is very similar to
the Slovak population, as we used to be one
country in past) (30). Cronbachs a in the present
sample was 0.94.
Information about medical variables was taken
from patient medical records. Medical variables
were as follows: dialysis modality, either current or
in the past (categorized as hemodialysis, peritoneal
dialysis or both methods), length of dialysis period
(either current or before transplantation), primary
nephrologic diagnosis, and the presence of comor-
bidity. Information about current serum creatinine
and current immunosuppression protocol was
retrieved in the group of transplanted patients as
well.
Statistics
Frequencies, means and standard deviations were
calculated for the sample description. Diﬀerences
in continuous variables between dialysis and
transplant patients as well as between dialysis
patients on waiting lists and transplant patients
were analyzed using the Mann–Whitney U-test and
Wilcoxon signed ranks test. Diﬀerences in categor-
ical variables between dialysis and transplant
patients as well as between dialysis patients on
waiting lists and transplant patients were analyzed
with the chi-square test and Fisher exact test. spss
16.0 was used for statistical analyses.
Results
Out of 151 dialyzed patients 93 were on awaiting list
for deceased-donor kidney transplantation (mean
age 49.2 ± 11.9 yr, 54 males and 39 females). The
mean age of the group of 87 transplanted patients
was 46.6 ± 13.1 yr (49 males, 38 females). After
matching, 124 patients (62 dialyzed patients on
waiting list and 62 transplant recipients) remained
for analysis.
Follow-up data 12 months following baseline
evaluation are available for 33 dialyzed patients on
a waiting list and 41 kidney transplant recipients.
The reasons for lack of follow-up data are as
follows. Two (2.2%) waiting-list patients and three
(3.4%) transplant recipients died; eight (8.6%)
waiting-list patients and 33 (37.9%) transplant
recipients refused to give informed consent or
provided incomplete questionnaires; 20 (21.5%)
waiting-list patients were transplanted; 14 (15.1%)
waiting-list patients were not yet 12 months after
baseline evaluation and ﬁve (5.7%) transplant
recipients were not yet 12 months after transplan-
tation; two (2.2%) waiting-list patients and one
(1.1%) transplant recipient were lost to follow-up;
and ﬁve (5.4%) waiting-list patients no longer ﬁt
the inclusion criteria.
Demographic and socioeconomic variables are
described in Table 1. We observed a trend towards
older age in the dialysis group (however, diﬀer-
ences were not signiﬁcant). Medical variables are
presented in Table 2. The majority of patients had
hemodialysis as their elimination modality, but this
was less frequent in the transplanted group than in
Table 1. Basic characteristics of all dialyzed
patients on a waiting list, all transplanted pa-
tients, and matched pairs of patients on a









Age (yr) 49.2 ± 11.9 46.6 ± 13.1 46.5 ± 11.3 48.0 ± 12.2
Gender (%)
Male 58.1 56.3 61.3 61.3
Female 41.9 43.7 38.7 38.7
Education (%)
Elementary 55.5 59.2 50.0 59.0
Secondary 35.6 35.2 37.1 36.1
University 8.9 5.6 12.9 4.9
Employment status (%)
Employed 11.8 10.3 14.5 11.3
Not employed 88.2 99.7 85.5 88.7
Housekeeping (h/wk) 21 ± 16 20 ± 19 22 ± 15 18 ± 18
Family status (%)
Single 19.2 25.0 19.2 27.7
Married 74.0 64.3 80.8 63.7
Divorced 0.0 3.6 0.0 4.3
Widowed 6.8 7.1 0.0 4.3
Figures are percentages or means ± standard deviations.
D-WL, dialysis patients on a waiting list; Tx, transplanted patients.
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the waiting list group (p £ 0.05). There were more
patients who switched elimination therapy (from
peritoneal dialysis to hemodialysis or vice versa) in
the transplant group compared to dialysis patients
on a waiting list (p £ 0.001). Patients on dialysis
diﬀered signiﬁcantly from those after transplanta-
tion in their primary nephrologic diagnosis – there
were more polycystic kidney diseases (p £ 0.05)
among the dialyzed patients. Dialyzed patients on
a waiting list had severe anemia (p £ 0.01) and
cancer (p £ 0.05) more often when compared to
transplant recipients. On the other hand, diabetes
mellitus was more frequent among transplant
recipients (p £ 0.05), and when the comorbidity
index was calculated, an insigniﬁcant trend to-
wards higher morbidity was observed among
dialyzed patients.
In the non-matched sample, dialysis patients on
a waiting list reported worse physical
(48.5 ± 21.4) and mental (58.6 ± 18.1) perceived
health status than patients after kidney transplan-
tation (55.7 ± 18.1 and 63.6 ± 18.2, p £ 0.05,
respectively). When patients after kidney trans-
plantation were compared to their matched pairs
on a waiting list, no diﬀerences in perceived health
status were found (Table 3). After the follow-up
12 months later, the physical perceived health
status of all waiting-list patients worsened, by
4.8 ± 14.8, and mental perceived health status
improved by 0.1 ± 18.1 (the change is not signif-
icant). Physical and mental perceived health status
of kidney transplant recipients improved by
0.4 ± 14.4 and 1.5 ± 15.6, respectively (also
not signiﬁcant). When matched pairs were com-
pared with regard to a change in perceived health
status, the diﬀerences between patients on a
waiting list and those after transplantation were
also not signiﬁcant. In addition, the change of
perceived health status was highly variable in
both groups; there were as many patients with
Table 2. Medical characteristics of all dialyzed
patients on a waiting list, all transplanted pa-
tients, and matched pairs of patients on a










Hemodialysis 88.3* 73.6 86.7 72.6
Peritoneal dialysis 10.5 11.1 13.3 11.3
Both modalities 1.2*** 15.3 0.0*** 16.1
Dialysis duration (yr) 3.6 ± 3.6 3.9 ± 2.7 3.5 ± 3.6 4.0 ± 2.8
Primary diagnosis (%)
Glomerulonephritis 31.5 38.0 33.9 35.5
Tubulointerstitial nephritis 26.9 29.6 25.8 27.4
Diabetic nephropathy 4.5 11.3 4.8 12.9
Polycystic kidneys 11.2* 2.8 8.1 3.2
Other or unknown 25.9 18.3 27.4 21.0
Co-morbidity (%)
Diabetes mellitus 12.2* 29.8 13.2* 31.2
Hypertension 93.2 100.0 90.6 100.0
Heart diseases 39.2 32.8 34.0 36.7
Stroke 12.2 8.6 11.3 10.2
Hepatitis 5.4 7.3 5.7 8.7
Severe anemia (Hb<100 g/L) 24.7** 12.0 26.4*** 10.2
Cancer 8.1* 0.0 9.4* 0.0
Severe bone disease 19.0 19.0 20.8 22.4
Co-morbidity index (%)
low-risk 6.7 13.9 6.5 6.5
intermediate-risk 48.3 44.4 48.4 48.4
high-risk 45.0 41.7 45.2 45.2
Serum creatinine (lmol/l) 137 ± 56 134 ± 46
Immunosuppression (%)
CsA + MMF + P 80.4 78.3
Tac + MMF + P 16.4 17.4
CsA + MMF 1.8 2.2
Tac + MMF 1.8 2.2
Figures are percentages or means ± standard deviations.
D-WL, dialysis patients on a waiting list; Tx, transplanted patients; CsA, cyclosporin A; MMF, mycophenolate
mofetil; P, prednisone; Tac, tacrolimus.
*Significant difference when compared to transplanted patients (p £ 0.05).
**Significant difference when compared to transplanted patients (p £ 0.01).
***Significant difference when compared to transplanted patients (p £ 0.001).
Rosenberger et al.
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dramatic improvement as with dramatic worsening
(Table 3).
Discussion
The present study conﬁrms that patients after
kidney transplantation feel better than those on
dialysis (15). The physical component of perceived
health status in particular is improved in transplant
patients. In contrast to previous research, we show
that this is not the case when the perceived health
status of transplant recipients is compared to that
of their dialysis matched pairs (having the same
age, gender and comorbidity) on a waiting list.
We evaluated the perceived health status of
incident kidney transplant recipients three months
after their transplant surgery. Three months after
transplantation seems to be suﬃcient time for most
patients wounds to heal and for them to adapt to
their new life situation. The frequency of medical
visits, blood tests and doses of immunosuppressive
drugs are reduced as well. In addition, there is
evidence that after three months the risk of death is
comparable between transplant recipients and
patients on waiting lists (31). Perceived health
status remained stable 12 months after transplan-
tation. On the other hand, the same (not signif-
icant) trend is visible in their matched dialysis pairs
on a waiting list.
Our ﬁndings are not in line with previous
research, and we think it is important to discuss
the possible reasons. Although the majority of
papers have conﬁrmed sharp diﬀerences in age
between the general dialysis population and kidney
transplant recipients (2, 8, 10, 11, 15, 18), this fact
is often neglected when interpreting results. In the
present study, the sample of all (non-matched)
dialyzed patients was older than transplant recip-
ients by an average of 10 yr (data for dialyzed
patients not on a waiting list for transplantation
are not shown in the tables). There are other
demographic and social variables which are
potential confounders. Our sample did not reveal
signiﬁcant diﬀerences in these variables, despite the
fact that dialyzed patients in our sample had a
diﬀerent distribution of family status than patients
after transplantation.
It is common to control for medical variables in
graft or patient survival analyses. Dialyzed patients
in the present study suﬀered more from cancer and
anemia when compared to transplant recipients,
while diabetes was more common among trans-
planted patients. But this fact is often neglected in
research focusing on diﬀerences in quality of life
among various end-stage renal disease treatment
modalities. Primary diagnosis, or comorbidity is
usually presented but seldom included in the
analyses (3, 10). Ultimately, the best measure
against confounding factors is to stratify the
sample or to conduct a matched pairs study, as
we did in our study (32).
Another important argument for the interpreta-
tion of conﬂicting results is the diﬀerent time of
data collection in the studies. Russell et al.
observed signiﬁcant improvement in quality of life
30.9 months after transplantation in 27 patients on
waiting lists who had been subsequently trans-
planted. This prospective study was published in
Transplantation in 1992 (21). In the early 1990s
Laupacis et al. evaluated 269 patients on waiting
lists; 168 of them were subsequently transplanted.
The authors prospectively followed-up patients for
24 months (data on about 76 patients were avail-
able at that time) and concluded that health-related
quality of life improved by 23% six months after
transplantation and remained improved thereafter
(2). Unfortunately, since 1996, when this study was
published in Kidney International, no similar
Table 3. Perceived health status (SF-36) of all dialyzed patients on a waiting list, all transplanted patients, and matched pairs of patients on a waiting list and
after transplantation
D-WL (N = 93) Tx (N = 87) Matched D-WL (N = 62) Matched Tx (N = 62)
Physical perceived health status (baseline) 48.5 ± 21.4* 55.7 ± 20.7 48.2 ± 22.1 52.3 ± 19.8
Mental perceived health status (baseline) 58.6 ± 18.1* 63.6 ± 18.2 57.0 ± 18.7 59.7 ± 18.9
N = 42 N = 45 N = 33 N = 41
Physical perceived health status (follow-up) 47.7 ± 19.5 54.7 ± 19.0 50.0 ± 18.5 53.6 ± 18.7
Mental perceived health status (follow-up) 60.1 ± 18.5 64.2 ± 17.0 62.0 ± 18.4 63.4 ± 17.0
Change in physical health status )4.8 ± 14.2 0.4 ± 14.4 )5.3 ± 15.3 0.0 ± 14.3
Change in mental health status 0.1 ± 18.1 1.5 ± 15.6 1.0 ± 19.5 1.3 ± 15.8
Figures are percentages or means ± standard deviations.
D-WL, dialysis patients on a waiting list; Tx, transplanted patients.
*Significant difference when compared to all transplanted patients (p £ 0.05).
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research paper has been presented. During the past
10–15 yr dialysis as well as transplantation practice
has changed signiﬁcantly. Comparing our trans-
planted patients with the population in the study
published in 1996 by Laupacis et al. reveals visible
diﬀerences: our patients were on average ﬁve yr
older, spent twice as much time on dialysis and
were less likely to be employed. These diﬀerences
visibly show that older and more ailing patients are
being transplanted today, which can surely aﬀect
outcomes (2).
The present study has some weaknesses that
need to be mentioned. The number of participants
was not high, as we included 180 patients with end-
stage renal disease treated by dialysis or transplan-
tation. The majority of studies on this topic
contained a similar number of patients, but there
are exceptions, unfortunately with no matching
(15) or matching for age and gender only (17). We
tried to manage the problem of case-mix by
matching for age, gender and comorbidity index.
However, even after matching the samples are not
fully equal as there are more cases with anemia and
cancer among dialyzed patients and more diabetics
among transplant recipients. Less anemia in the
transplant group is not surprising because it is
connected with functioning kidneys while the
higher proportion of diabetics among transplant
recipients is due to the manifestation of post-
transplant diabetes mellitus after application of
steroids and calcineurin inhibitors. As these facts
are a part of dialysis/transplantation, it is prob-
lematic to control for them. Another problem for
the interpretation of the present research lies in the
tool used. The SF-36 is a questionnaire designed
for evaluation of perceived health status. This
measure is deﬁnitely not equivalent to quality of
life, as the latter term covers much broader aspects.
The diﬀerences in instruments might therefore be
the source of contrary conclusions. Survival bias
might also be a source of inaccuracy in our results,
because we invited transplant recipients with func-
tional graft after three months. Including those
with graft failure before the third month (or those
who died) would decrease the diﬀerences between
the groups. An additional problem is the follow-up
after 12 months, as we were able to examine only
45% of the waiting-list patients and half of the
transplant recipients. While power analysis at base-
line provided acceptable results (power 46–72%),
it was merely fair (up to 20%) upon follow-up
examination. Continuation in this prospective re-
search is therefore necessary, but problematic
because a signiﬁcant numbers ofwaiting-list patients
are transplanted, die or move to a non-waiting list
category during the follow-up period.
Our aim was to conduct a study coming from
real life, and therefore we included all new trans-
plant recipients from our centre as well as all
waiting-list patients from four dialysis centers from
the same region. This approach provides the
opportunity to generalize the results to the whole
transplant/waiting list population.
Perceived health status in patients is much better
after kidney transplantation than in those on
dialysis. However, this statement may be inﬂu-
enced by the selection procedure, as only some
dialyzed patients are put onto a waiting list and
some of them are actually transplanted. After
applying matching criteria (age, gender and com-
orbidity), diﬀerences in perceived health status
disappear. Some patients perceive a dramatic
improvement of health status shortly after
transplantation, while others perceive a negative
experience. Individual characteristics (medical and
non-medical) possibly play a more important role
than the type of therapy. Patients on dialysis
awaiting transplantation (together with their neph-
rologists) expect improvement in their health status
after successful transplantation, but often encoun-
ter new health complaints, including the adverse
eﬀects of immunosuppressive drugs, fear of rejec-
tion and infection, or anxiety about long-term
kidney function (33–36).
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